Montgomery Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$780K Hold
650
0.24% 65
2026
Q1
$598K Hold
650
0.2% 69
2025
Q4
$699K Hold
650
0.25% 55
2025
Q3
$496K Hold
650
0.17% 68
2025
Q2
$507K Hold
650
0.2% 64
2025
Q1
$537K Hold
650
0.21% 59
2024
Q4
$502K Hold
650
0.2% 62
2024
Q3
$576K Hold
650
0.21% 55
2024
Q2
$588K Hold
650
0.23% 51
2024
Q1
$506K Sell
650
-350
-35% -$249K 0.19% 58
2023
Q4
$583K Hold
1,000
0.18% 60
2023
Q3
$537K Hold
1,000
0.19% 61
2023
Q2
$469K Hold
1,000
0.16% 67
2023
Q1
$343K Hold
1,000
0.12% 69
2022
Q4
$366K Hold
1,000
0.13% 68
2022
Q3
$324K Hold
1,000
0.13% 68
2022
Q2
$325K Hold
1,000
0.13% 67
2022
Q1
$286K Hold
1,000
0.1% 73
2021
Q4
$276K Hold
1,000
0.09% 73
2021
Q3
$231K Hold
1,000
0.09% 78
2021
Q2
$229K Buy
+1,000
New +$201K 0.08% 79

Other funds holding LLY

Montgomery Investment Management's LLY Position: Q2 2026 in Review

Montgomery Investment Management held its Eli Lilly (LLY) position steady in Q2 2026 at 650 shares worth $780K. The position accounts for 0.24% of the portfolio, ranked #65.

Montgomery Investment Management first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Montgomery Investment Management held 650 shares of Eli Lilly worth $780K as of Q2 2026.
  • Montgomery Investment Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.24% of Montgomery Investment Management's portfolio in Q2 2026, its #65 holding.
  • Montgomery Investment Management first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Montgomery Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.